ArticleScientific reports2026
Multimorbidity trajectories and their sex-specific impacts on risk of mortality and re-hospitalisation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The clinical presentation of disease is complicated by multimorbidity, underscoring the need to clarify its effects and identify intervention targets. Using whole UK Biobank hospital inpatient data, we performed the first comprehensive, sex-stratified analysis of age- and morbidity-adjusted mortality and re-hospitalisation outcomes of multimorbidity accrual, both total and specific historical diagnoses, for a range of presenting diagnoses. One-year mortality and re-hospitalisation risks associated with the presenting total accrued multimorbidity of an individual varied markedly with the presenting diagnosis, ranging from no effect to a 1.58-fold increase per diagnosis, highlighting strong context-dependent risks of multimorbidity accrual. Sex disparities in these context-dependent effects were greater for re-hospitalisation than mortality risk. Identification and risk-modelling of non-random trajectories of specific diagnoses revealed especially high-risk multimorbidity (1.16-16.18 fold resultant increases in 1-year mortality/re-hospitalisation) with predictable orders of presentation, suggesting potential points of focused intervention. Notably, a history of diagnosed substance use in males markedly amplified mortality and re-hospitalisation rates, particularly in presentations of anaemias and infections, as did cardiometabolic histories in men presenting with certain digestive diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.